VANI Vivani Medical, Inc.: institutional ownership and insider trading
39 funds reported holding $8.35M of Vivani Medical, Inc. in their latest 13F filings; in Q2 2026 funds net sold $504K, with 6 new positions and 13 funds selling out; over the last 12 months insiders bought $24.6M and sold $0 on the open market.
VANI revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$6.37M, EPS -0.07
- Quarter ended Mar 31, 2026: revenue n/a, net income −$6.78M, EPS -0.08
- Quarter ended Dec 31, 2025: revenue n/a, net income $46.6M, EPS -0.09
- Quarter ended Sep 30, 2025: revenue n/a, net income −$6.53M, EPS -0.11
Largest institutional holders of VANI
- VANGUARD CAPITAL MANAGEMENT LLC — $2.19M
- VANGUARD GROUP INC — $1.91M
- Tanager Wealth Management LLP — $753K
- GEODE CAPITAL MANAGEMENT, LLC — $729K
- TUDOR INVESTMENT CORP ET AL — $510K
- COMMONWEALTH EQUITY SERVICES, LLC — $410K
- VANGUARD FIDUCIARY TRUST CO — $404K
- BlackRock, Inc. (BLK) — $374K
- MONETARY MANAGEMENT GROUP INC — $241K
- STATE STREET CORP (STT, STT-PG) — $192K
Recent VANI insider trades
- Jul 15, 2026: Williams Gregg bought 793,650 shares ($1000K)
- Jun 15, 2026: Williams Gregg bought 1,587,301 shares ($2.00M)
- May 15, 2026: Williams Gregg bought 1,587,301 shares ($2.00M)
- Apr 15, 2026: Williams Gregg bought 1,587,301 shares ($2.00M)
5%+ owners
- Williams Gregg: 47.1% (Schedule 13D/A, filed May 19, 2026)